Apocynin Inhibits the Upregulation of TGF-β1 Expression and ROS Production Induced by TGF-β in Skeletal Muscle Cells
Abstract
Background Pure apocynin, which can be traditionally isolated and purified from several plant species such as Picrorhiza kurroa Royle ex Benth (Scrophulariaceae), acts as an inhibitor of nicotinamide adenine dinucleotide phosphate (NADPH) oxidase (NOX) activity inhibiting its production of reactive oxygen species (ROS). Transforming growth factor type beta 1 (TGF-β1) is a growth factor that produces inhibition of myogenesis, diminution of regeneration and induction of atrophy in skeletal muscle. The typical signalling that is activated by TGF-β involves the Smad pathway.Purpose To evaluate the effect of TGF-β and the effect of apocynin on TGF-β1 expression in skeletal muscle cells.Study design Controlled laboratory study. In vitro assays were performed with C2C12 cells incubated with TGF-β1 in presence or absence of apocynin (NOX inhibitor), SB525334 (TGF-β-receptor I inhibitor), or chelerythrine (PKC inhibitor).Methods TGF-β1 and atrogin-1 expression was evaluated by RT-qPCR and/or ELISA; Smad3 phosphorylation by western blot; Smad4 nuclear translocation by indirect immunofluorescence; and ROS levels by DCF probe fluorescent measurements.Results We show that myoblasts respond to TGF-β1 by increasing its own gene expression in a time- and dose-dependent fashion which was abolished by SB525334 and siRNA for Smad2/3. TGF-β1 also induced ROS. Remarkably, apocynin inhibited the TGF-β1 induced ROS as well as the autoinduction of TGF-β1 gene expression. We also show that TGF-β-induced ROS production and TGF-β1 expression require PKC activity as indicated by the inhibition using chelerythrine.Conclusion These results strongly suggest that TGF-β induces its own expression through a TGF-β-receptor/Smad-dependent mechanism and apocynin is able to inhibit this process, suggesting that requires NOX-induced ROS in skeletal muscle cells.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
TGF-β regulates several processes in skeletal muscle disease including inhibition of myogenesis, diminution of regeneration, and induction of muscle atrophy.
“TGF-β, a classical modulator of skeletal muscle, regulates several processes in skeletal muscle disease including inhibition of myogenesis, diminution of regeneration, and induction of muscle atrophy.”
From Nutraceuticals in the Prevention and Treatment of the Muscle Atrophy (2021) · cites this paper as [140]
Apocynin prevents TGF-β-induced muscle atrophy in C2C12 myotubes through inhibiting TGF-β/Smad signaling.
“Apocynin, isolated and purified from Picrorhiza kurroa Royle ex Benth, prevents TGF-β-induced muscle atrophy in C2C12 myotubes through inhibiting TGF-β/Smad signaling [140].”
From Nutraceuticals in the Prevention and Treatment of the Muscle Atrophy (2021) · cites this paper as [140]
The citation lists haven’t been fetched yet
References 40 · Cited by 20
- Authors
- Abrigo, J., Morales, M. G., Simon, F., Cabrera, D., Capua, G. D., & Cabello-Verrugio, C.
- Affiliations
- Universidad Andrés Bello (CL)
- Universidad Bernardo O'Higgins (CL)
- Venue
- Phytomedicine
- Publisher
- Elsevier BV
- Published
- 2015-09
- Volume
- 22
- Issue
- 10
- Pages
- 885-893
- ISSN
- 0944-7113 (ISSN-L)
- OpenAlex
- W1265330817
- Cited by
- 20
- References
- 40
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 1 · 2022: 1 · 2021: 2 · 2019: 2 · 2018: 3 · 2017: 2 · 2016: 5
- FWCI
- 1.45
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Phytomedicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Association-Francaise Contre Les Myopathies (AFM 16670 (CCV), FONDECYT 1120380, 3130593, 3140396, 1121078)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Keywords
- apocynin, TGF-β1, reactive oxygen species, NADPH oxidase, skeletal muscle, myoblasts, Smad3 phosphorylation, protein kinase C, atrogin-1, muscle atrophy, TGF-beta type I receptor, Picrorhiza kurroa
- MeSH terms
- Acetophenones, Animals, Cell Line, Imidazoles, Protein Kinase C, Quinoxalines, Up-Regulation, Transforming Growth Factor beta, Reactive Oxygen Species, Muscle Fibers, Skeletal, Mice, Smad2 Protein, Smad3 Protein, Benzophenanthridines, Transforming Growth Factor beta1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review